Characterization of kaposiform lymphangiomatosis tissue-derived cells.
Akifumi NozawaMichio OzekiShiho YasueSaori EndoKei NoguchiTomohiro KanayamaHiroyuki TomitaYoko AokiHidenori OhnishiPublished in: Pediatric blood & cancer (2021)
Inhibition of the RAS/MAPK and PI3K/AKT/mTOR pathways may represent potential therapeutic targets in KLA. These patient-derived KLA cell lines will be useful research tools to elucidate KLA etiology, and could pave the way for basic, translational, and preclinical studies of this disease.